Detalhe da pesquisa
1.
Loss of Pfizer (BNT162b2) Vaccine-Induced Antibody Responses against the SARS-CoV-2 Omicron Variant in Adolescents and Adults.
J Virol
; 96(17): e0058222, 2022 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35976000
2.
Feasibility of Social Media Recruitment for Orofacial Cleft Genetic Research.
Cleft Palate Craniofac J
; 59(6): 701-707, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34121473
3.
SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination.
N Engl J Med
; 386(11): 1088-1091, 2022 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35081298
4.
Persistence of Vascular Calcification after Reversal of Uremia.
Am J Pathol
; 187(2): 332-338, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27939134
5.
Infants and young children generate more durable antibody responses to SARS-CoV-2 infection than adults.
medRxiv
; 2023 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37090559
6.
Infants and young children generate more durable antibody responses to SARS-CoV-2 infection than adults.
iScience
; 26(10): 107967, 2023 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37822504
7.
Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity.
bioRxiv
; 2023 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37662390
8.
Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity.
Res Sq
; 2023 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37790523
9.
Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough Infections.
Blood Cancer Discov
; 4(2): 106-117, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36511813
10.
Pre-existing SARS-CoV-2 immunity influences potency, breadth, and durability of the humoral response to SARS-CoV-2 vaccination.
Cell Rep Med
; 3(4): 100603, 2022 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35480625
11.
Durability of immune responses to the BNT162b2 mRNA vaccine.
Med
; 3(1): 25-27, 2022 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35590141
12.
Antibody response to SARS-CoV-2 mRNA vaccine in lung cancer patients: Reactivity to vaccine antigen and variants of concern.
medRxiv
; 2022 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35018383
13.
mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant.
Cell Rep Med
; 3(2): 100529, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35233550
14.
Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron Variant.
J Clin Oncol
; 40(33): 3808-3816, 2022 11 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35759727
15.
mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variant.
bioRxiv
; 2021 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34981056
16.
Booster of mRNA-1273 Strengthens SARS-CoV-2 Omicron Neutralization.
medRxiv
; 2021 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34931200